Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives

NCT02028026 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02028026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
April 30, 2013
Completion date
April 30, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, comorbidity, major depressive disorder